Fidelity Disruptive Medicine Fund - Loyalty Class 1
$11.52
Fidelity Disruptive Medicine Fund - Loyalty Class 1 (FRXLX) Forecast
See the Price Targets and Ratings of:
FRXLX Analyst Rating
Moderate Buy
67ConsensusRatings
48Buy18Hold1Sell
Based on the Wall Street analyst consensus for 67 of FRXLX’s holdings.
FRXLX Analyst Price Target
Average Price Target
$14.11▲(22.46% Upside)
Based on Wall Street analyst 12-month price targets for 67 of Fidelity Disruptive Medicine Fund - Loyalty Class 1’s holdings in the last 3 months. The average price target is $14.11 with a high forecast of $17.13 and a low forecast of $11.27. The average price target represents a 22.46% change from the last price of $11.52.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$17.13
Average$14.11
Low$11.27
Past 12 Months12 Month Forecast$10$12$14$16$18Feb2026May2026Aug2026Nov2026Nov2027
What is FRXLX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 67 of FRXLX’s holdings, Fidelity Disruptive Medicine Fund - Loyalty Class 1’s 12-month average price target is $14.11.
What is FRXLX’s upside potential, based on the analysts’ average price target?
FRXLX’s average price target of $14.11 represents a 22.46% upside from its last price of $11.52.
Is FRXLX a Buy, Sell or Hold?
Fidelity Disruptive Medicine Fund - Loyalty Class 1 has a consensus rating of Moderate Buy, based on the analyst consensus for 67 of FRXLX’s holdings: 48 rated Buy, 18 rated Hold and 1 rated Sell.
What is Fidelity Disruptive Medicine Fund - Loyalty Class 1’s price target?
The average price target for Fidelity Disruptive Medicine Fund - Loyalty Class 1 is $14.11, based on Wall Street analyst 12-month price targets for 67 of FRXLX’s holdings, issued in the past 3 months. The highest price target is $17.13 and the lowest is $11.27. The average price target represents a 22.46% increase from the last price of $11.52.
How can I buy shares of FRXLX?
You can buy shares of FRXLX through a brokerage account. Compare brokers on our Best Online Brokers page.